The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermans, I. F.
Right arrow Articles by Cerundolo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermans, I. F.
Right arrow Articles by Cerundolo, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2007, 178: 2721-2729.
Copyright © 2007 by The American Association of Immunologists, Inc.

Dendritic Cell Function Can Be Modulated through Cooperative Actions of TLR Ligands and Invariant NKT Cells1

Ian F. Hermans2,3,*,{dagger}, Jonathan D. Silk2,*, Uzi Gileadi2,*, S. Hajar Masri*, Dawn Shepherd*, Kathryn J. Farrand{dagger}, Mariolina Salio* and Vincenzo Cerundolo4,*

* Tumour Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom; and {dagger} Malaghan Institute of Medical Research, Wellington, New Zealand

The quality of signals received by dendritic cells (DC) in response to pathogens influences the nature of the adaptive response. We show that pathogen-derived signals to DC mediated via TLRs can be modulated by activated invariant NKT (iNKT) cells. DC maturation induced in vivo with any one of a variety of TLR ligands was greatly improved through simultaneous administration of the iNKT cell ligand {alpha}-galactosylceramide. DC isolated from animals treated simultaneously with TLR and iNKT cell ligands were potent stimulators of naive T cells in vitro compared with DC from animals treated with the ligands individually. Injection of protein Ags with both stimuli resulted in significantly improved T cell and Ab responses to coadministered protein Ags over TLR stimulation alone. Ag-specific CD8+ T cell responses induced in the presence of the TLR4 ligand monophosphoryl lipid A and {alpha}-galactosylceramide showed faster proliferation kinetics, and increased effector function, than those induced with either ligand alone. Human DC exposed to TLR ligands and activated iNKT cells in vitro had enhanced expression of maturation markers, suggesting that a cooperative action of TLR ligands and iNKT cells on DC function is a generalizable phenomenon across species. These studies highlight the potential for manipulating the interactions between TLR ligands and iNKT cell activation in the design of effective vaccine adjuvants.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was funded by Cancer Research U.K. (Programme Grant C399-A2291), Harry Mahon Cancer Research Trust, Medical Research Council and FP6 project DC-VACC (LSHB-CT-2003-503037) (to V.C.), and a New Zealand Health Research Council Sir Charles Hercus Fellowship (to I.F.H.).

2 I.F.H., J.D.S., and U.G. contributed equally to this work.

3 Current address: Malaghan Institute of Medical Research, P.O. Box 7060, Wellington, New Zealand.

4 Address correspondence and reprint requests to Dr. Vincenzo Cerundolo, Tumour Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, U.K. E-mail address: vincenzo.cerundolo{at}imm.ox.ac.uk

5 Abbreviations used in this paper: DC, dendritic cell; {alpha}-GalCer, {alpha}-galactosylceramide; CMTMR, chloromethyl-benzoyl-aminotetramethyl-rhodamine; Flu-NP, influenza nucleoprotein; iNKT, invariant NKT; MPL, monophosphoryl lipid A; poly(I:C), polyinosinic polycytidylic acid; TCM, central memory T cell; TE, effector T cell; tg, transgenic; vacc-OVA, recombinant vaccinia virus encoding full-length chicken OVA.




This article has been cited by other articles:


Home page
BloodHome page
S.-i. Fujii, A. Goto, and K. Shimizu
Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity
Blood, April 30, 2009; 113(18): 4262 - 4272.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Vas, J. Mattner, S. Richardson, R. Ndonye, J. P. Gaughan, A. Howell, and M. Monestier
Regulatory Roles for NKT Cell Ligands in Environmentally Induced Autoimmunity
J. Immunol., November 15, 2008; 181(10): 6779 - 6788.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. G. Joyee, H. Qiu, Y. Fan, S. Wang, and X. Yang
Natural Killer T Cells Are Critical for Dendritic Cells to Induce Immunity in Chlamydial Pneumonia
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Silk, M. Salio, B. G. Reddy, D. Shepherd, U. Gileadi, J. Brown, S. H. Masri, P. Polzella, G. Ritter, G. S. Besra, et al.
Cutting Edge: Nonglycosidic CD1d Lipid Ligands Activate Human and Murine Invariant NKT Cells
J. Immunol., May 15, 2008; 180(10): 6452 - 6456.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. A. Lang, T. S. Devera, and M. L. Lang
Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production
Blood, February 15, 2008; 111(4): 2158 - 2162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.